tobramycin has been researched along with Immunologic Deficiency Syndromes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bukhteeva, ER; Vereshchagin, IA; Zhabotina, LA; Zhuravleva, OD | 1 |
| Alestig, K; Bergmark, J; Bergström, T; Hultberg, B; Jagenburg, R; Olaisson, L; Rödjer, S; Trollfors, B; Westin, J | 1 |
1 trial(s) available for tobramycin and Immunologic Deficiency Syndromes
| Article | Year |
|---|---|
Treatment of septicaemia in immunocompromised patients with ceftazidime or with tobramycin and cefuroxime, with special reference to renal effects.
Topics: Adult; Aged; Ceftazidime; Cefuroxime; Female; Humans; Immunologic Deficiency Syndromes; Kidney; Kidney Function Tests; Male; Middle Aged; Random Allocation; Sepsis; Tobramycin | 1987 |
1 other study(ies) available for tobramycin and Immunologic Deficiency Syndromes
| Article | Year |
|---|---|
[Antibiotic therapy of intestinal infections complicated by toxicosis and exicosis in children with immunodeficiency syndromes].
Topics: Acute Disease; Combined Modality Therapy; Cytochrome c Group; Diarrhea, Infantile; Enterocolitis; Gentamicins; Humans; Immunization, Passive; Immunologic Deficiency Syndromes; Infant; Polymyxin B; Salmonella Infections; Tobramycin; Toxemia | 1992 |